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ABSTRACT  1 
Background: One approach to boost influenza vaccination coverage has been to expand 2 
immunization authority. In 2012, the province of Ontario gave community pharmacists the 3 
authority to administer the influenza vaccine.  4 
Objective: This study investigates the perspectives of Ontario pharmacy patrons, who had not 5 
recently received this vaccine from a pharmacist, regarding this pharmacist service.  6 
Methods: A survey was administered in six Ontario community pharmacies to pharmacy 7 
patrons who had not received an influenza vaccination from a pharmacist during the previous 8 
year. The instrument included questions about influenza vaccination, and knowledge of and 9 
attitudes toward vaccines and pharmacist-administered immunization.   10 
Results: A total of 541 pharmacy patrons completed the survey (53.9% response rate). About 11 
one-third (30.5%) of respondents were not aware that pharmacists could give the influenza 12 
vaccine, with younger individuals being less likely to be aware (OR 0.48, 95% CI 0.29–0.77, 13 
p<0.05) and less likely to receive the vaccine annually (OR 0.28, 95% CI 0.19–0.42, p<0.05). 14 
Leading reasons respondents gave as to why they did not  receive their influenza vaccine from a 15 
pharmacist included not wanting or feeling they needed to be immunized (41.6%) and being 16 
used to receiving the vaccine from a physician (16.5%). Concerns about the experience and 17 
training of pharmacists and lack of privacy in a community pharmacy were uncommon.  18 
Conclusion: Reduced awareness of the availability of pharmacist-provided influenza vaccine is 19 
still common. Pharmacists have a significant opportunity to address lack of awareness and 20 
vaccine hesitancy issues. They can promote this service to increase influenza vaccination rates 21 
among pharmacy patrons who do not utilize this professional service. 22 
Keywords: Pharmacist, immunization, influenza, patrons, patients, survey, awareness, vaccine 23 
hesitancy 24 
Funding: This study was conducted as part of the Ontario Pharmacy Evidence Network (OPEN) 25 
and funded by the Government of Ontario. The views expressed in this article are those of the 26 
















Highlights:  28 
• The public’s awareness of pharmacist-administered vaccinations can be further 29 
enhanced 30 
• Vaccine hesitancy is a common reason why individuals are not being vaccinated by 31 
pharmacists  32 
• Pharmacy patrons indicate they would get vaccinated if a health care professional 33 
recommended it 34 
• Enhanced advertising and accessibility might further attract the public to this pharmacist 35 

















Pharmacist scope of practice has expanded greatly in North America over the past 20 years and 38 
with it a gamut of professional services that community pharmacists can provide. These 39 
services include renewal and extension of prescriptions as well as administration of vaccines.
1
 40 
In the United States, pharmacists have been allowed to vaccinate in some jurisdictions since the 41 
mid-1990s. By 2009, all 52 states and territories had granted pharmacists the authority to 42 
immunize. Nonetheless, the vaccine type, extent of authority, and restrictions on the age of 43 
immunization recipients vary from one state to the next. However, regardless of jurisdiction, all 44 
community pharmacists in the United States can administer the influenza vaccine.
2
 An 45 
increasing number of countries now allow pharmacists to administer influenza vaccinations.
3
 In 46 
Canada, pharmacist immunization authority has grown from two provinces in 2009, driven in 47 
part by a need to respond to the anticipated H1N1 pandemic,
4,5
 to nine of ten provinces as of 48 
2016.
1
 In Ontario — Canada’s most populous province — pharmacists were granted the 49 
authority to administer the influenza vaccine during the fall of 2012. Pharmacists gave some 50 
250,000 influenza shots that year- a figure that tripled to 750,000 doses during the next 51 
influenza season.
6
 Several studies and systematic reviews have documented the impact this 52 
North American-wide expansion of pharmacist’s immunization authority has had on increasing 53 
influenza vaccination rates substantially.
7-13
 However, further enhancement of influenza 54 
vaccination rates is still needed. The most recent estimates from the Canadian population in 55 
2013 revealed that only 31% received seasonal influenza vaccine in the previous 12 months.
14
 56 
Understanding the public’s perception of the role of pharmacists as immunizers can enhance 57 
uptake of this service and address concerns the public may have. Previous studies of clients 58 
who had received a pharmacist-administered vaccine found high satisfaction levels, great 59 
appreciation of the knowledge and professionalism of pharmacists, high levels of intent to 60 
return to a pharmacist for future immunizations, and willingness to recommend pharmacists as 61 
immunizers to others.
15-23
 However, these studies did not explore the reasons of not receiving a 62 
vaccination from a pharmacist among individuals who did not get this service. Blake et al
15
 63 
















within a family health team, in a jurisdiction where the service was recently introduced, few 65 
individuals were able to recall that pharmacists can administer vaccines. Patients also 66 
expressed concerns that community pharmacies were not an appropriate venue to receive a 67 
vaccine. Additionally, they questioned whether pharmacists were qualified to immunize. While 68 
the literature offers insight into the experience of individuals who have been immunized by a 69 
pharmacist, gaps remain in understanding why individuals have not participated in pharmacist-70 
administered influenza vaccinations, especially in a community pharmacy setting.  71 
As the province of Ontario had recently granted pharmacists the authority to provide influenza 72 
immunizations, we had an opportunity to capture the perspectives of pharmacy patrons about 73 
this new professional service. Accordingly, the aims of this study were to determine (1) the 74 
proportion of pharmacy patrons who were aware that pharmacists are able to administer the 75 
influenza vaccine, (2) factors and changes that need to be made for pharmacy patrons to 76 
increase willingness to access this service in the future, and (3) if the age of pharmacy patrons 77 
affects their awareness and perceptions of pharmacist-administered influenza immunizations.  78 
METHODS 79 
This was a quantitative cross-sectional survey study conducted over a period of two weeks 80 
(September 18th to October 1st) after the 2013/14 influenza season and prior to the 2014/15 81 
influenza season (when influenza vaccines are usually administered) at six community 82 
pharmacies in the Greater Toronto Area-Canada’s most populous metropolitan region with 83 
more than 2,400 pharmacies. These community pharmacies belong to the largest national retail 84 
chain in Canada. The sample of six pharmacies was a convenience sample that was selected to 85 
include both urban and suburban locations and had offered immunizations during the previous 86 
influenza season. Pharmacy patrons aged 18 or older, can communicate in English, and who 87 
had not received the influenza vaccination from a pharmacist during the past year were eligible 88 
to be included in the study. 89 
The survey used in this study was developed specifically for this study. This survey sought to 90 
assess awareness, experience, attitudes, and beliefs about pharmacists as immunizers among 91 
















past year. The survey included questions on knowledge of pharmacists as immunizers, influenza 93 
vaccination experience (how often, from which healthcare providers in the past/future), 94 
attitudes toward pharmacists as immunizers (willingness to receive the vaccine from a 95 
pharmacist, changes that might increase the likelihood of receiving the vaccine from a 96 
pharmacist), general attitudes toward vaccines, and personal demographics. Respondents could 97 
choose one or more answers to the same question in the survey. Modifications to the survey 98 
were made based on qualitative feedback obtained from pilot testing with five pharmacists, 99 
pharmacy students and non-pharmacist research staff. Both face and content validity were 100 
examined in this pilot testing. The modified survey was then used in the study. 101 
As previous research has noted concerns regarding bias in pharmacist-administered surveys of 102 
client perspectives,
24
 a research assistant−who had not been in, employed by, or involved with 103 
any of the six community pharmacies previously-administered the survey. The research 104 
assistant spent two days at each community pharmacy. Adult pharmacy patrons who were in 105 
the pharmacy but were not receiving a professional pharmacist’s service were approached and 106 
informed, using scripted words, of the purpose of the survey and asked if they would be willing 107 
to answer an eligibility question. Those who met the inclusion criteria and agreed to participate 108 
were given a handout outlining the study and consent details. Participants were offered the 109 
option to complete a paper or iPad version of the questionnaire in the store, or to provide their 110 
email address to complete the questionnaire by email within the next week. All versions of the 111 
questionnaire were identical. Survey questions are available in Appendix 1. Both the iPad and 112 
emailed versions of the survey were delivered using Qualtrics online survey software (Provo, 113 
Utah, USA). All participants were thanked and offered nominal compensation (piece of candy) 114 
in appreciation of their participation. The study received approval from human research ethics 115 
boards at the University of Waterloo and University of Toronto. 116 
Frequencies and percentages from survey responses were analyzed using SAS 9.4 (SAS Institute 117 
Inc., Cary, NC, USA). Differences in frequency distributions between older participants (≥ 65) 118 
and younger participants (<65) were assessed using the chi-square test, and relative risk was 119 
estimated by calculating odds ratios (ORs) with 95% confidence intervals (95% CI).
25
















RESULTS  121 
In total, 1,004 individuals from six community pharmacies were invited to participate in the 122 
survey. Of these, 72 (7.1%) were ineligible because they had been vaccinated by a pharmacist in 123 
the past year and 391 (38.9%) either declined to participate immediately or did not respond to 124 
the email directing them to the questionnaire. In total, 541 (53.9% of invited individuals) 125 
completed the survey using the paper (n=433, 80.0%), iPad (n=93, 17.2%) or the emailed 126 
version (n=15, 2.8%). Of the 90 individuals who provided an email address, 82 emails were 127 
delivered (8 bounced back) and 15 (16.7%) responded to the survey invitation. Almost two-128 
thirds of the survey sample (n=346, 64%) were female, 398 (73.6%) were less than 65 years old, 129 
and 262 (48.4%) were born outside Canada. Respondent characteristics are provided in Table 1. 130 





Missing 15 (2.8%) 
18–25 48 (8.9%) 
26–40 125 (23.1%) 
41–55 149 (27.5%) 
56–64 76 (14%) 
65–79 103 (19%) 
80+ 25 (4.6%) 
Gender 
Missing 11 (2%) 
Man 182 (33.6%) 
Woman 346 (64%) 
Other 2 (0.4%) 
Born in 
Canada? 
Missing 13 (2.4%) 
Yes 266 (49.2%) 
No 262 (48.4%) 
Ethnic origin 
Missing 16 (3.0%) 
Aboriginal/First Nations/Metis 3 (0.6%) 
Latin/Central/South American 22 (4.1%) 
North American 176 (32.5%) 
Caribbean 31 (5.7%) 
Asian (includes Middle East, South Asia, etc.) 104 (19.2%) 
African 21 (3.9%) 
European 165 (30.5%) 

















Almost two-thirds of respondents (n=333, 61.6%) indicated they were either likely or very likely 133 
to get a vaccine that had been recommended by a health professional. A small proportion of 134 
individuals indicated that they were unlikely or very unlikely to get a vaccine that has been 135 
recommended by a health professional (n=69, 12.8%). More than one-third of respondents 136 
reported that they had never received an influenza vaccination (n=200, 37.0%), whereas 185 137 
(34.2%) indicated they receive it every year. The remainder of respondents either received the 138 
vaccine occasionally every 2 to 3 years (n=116, 21.4%), received it last year for the first time 139 
(n=13, 2.4%), or planned on getting it for the first time this year (n=15, 2.8%).   140 
Younger individuals (<65) were less likely to receive the vaccine every year than were 141 
individuals 65 years or older (OR 0.28, 95% CI: 0.19–0.42, p<0.01). However, sex and place of 142 
birth did not affect the likelihood of receiving the vaccine every year (OR 1.18, 95% CI: 0.81–143 
1.72, p=0.38 for male vs. female and OR 1.02, 95% CI: 0.71–1.46, p=0.91 for patrons born in 144 
Canada vs. patrons born outside of Canada). The family physician’s office was the most 145 
common location to receive the vaccine (n= 183, 33.8%), followed by the workplace (n=32, 146 
5.9%) and public health clinics (n=14, 2.6%). Few individuals indicated that they are at higher 147 
risk of contracting influenza or experiencing influenza-related complications because of a 148 
weakened immune system (e.g., due to illness or treatments) (n= 32, 5.9%), having a chronic 149 
illness (e.g., diabetes or hypertension) (n=48, 8.9%), or being pregnant (n=7, 1.3%). 150 
Slightly less than one-third of respondents (n=165, 30.5%) indicated that they were not aware 151 
that pharmacists could administer the influenza vaccine. Younger individuals (<65) were even 152 
less likely to be aware of the availability of vaccination through pharmacists (OR 0.48, 95%CI 153 
0.29 to 0.77, p<0.01). Among respondents who were aware that pharmacists could administer 154 
the influenza vaccine, individuals were made aware mainly by TV or radio advertisements 155 
(n=147, 39.1%), or directly from the pharmacy itself (n=143, 38.0%). Other means of awareness 156 
included word of mouth (n=62, 16.5%), newspaper ads (n=53, 14.1%), and doctors’ offices 157 
















The most common reasons survey respondents provided for not receiving the vaccine from 159 
community pharmacists was not wanting or needing the influenza vaccine (n=225, 41.6%), not 160 
having the knowledge that pharmacists can administer the vaccine (n=98, 18.1%), being more 161 
accustomed to getting the vaccine from a doctor or nurse (n=89, 16.5%), or finding influenza 162 
vaccination to be more convenient from a doctor or a nurse (n=63, 11.6%). Pharmacy-specific 163 
concerns such as potential lack of privacy (n=7, 1.3%) or inadequate pharmacist experience 164 
(n=6, 1.1%), and training to provide the vaccine (n=2, 0.4%) were expressed uncommonly. Table 165 
2 provides all patron responses for not receiving the influenza vaccine from a community 166 
pharmacist.  167 
Table 2: Pharmacy patron reasons for not getting the flu shot from a pharmacist in the past 168 
year 169 
Reason (More than one reason could be chosen) Frequency 
(n=541) 
I did not want/need the flu shot 225 (41.6%) 
I did not know pharmacists provided the flu shot 98 (18.1%) 
I’m used to getting it from my doctor/nurse 89 (16.5%) 
It’s more convenient to get from my doctor/nurse 63 (11.6%) 
Other 54 (10%) 
No reason, it just did not happen 37 (6.8%) 
I have more trust in my doctor/nurse 29 (5.4%) 
I got elsewhere 26 (4.8%) 
Not enough privacy at a pharmacy 7 (1.3%) 
Pharmacists do not have enough experience in this area 6 (1.1%) 
Pharmacists do not have enough training in this area  2 (0.4%) 
The wait time is too long in a pharmacy 2 (0.4%) 
It’s difficult to get to the pharmacy  0 (0%) 
 170 
The family doctor’s office was the most common intended future location for influenza 171 
vaccination among respondents (n= 144, 26.6%), with community pharmacies at 11.5% (n=62).  172 
Work place (n=28, 5.2%) and public health clinics (n=6, 1.1%) being lower preference locations.  173 
When asked about future intention to be immunized, 55.7% (n=301) of respondents indicated 174 
















indicated they might be willing. About one-third of the respondents (n=186, 34.4%) stated that 176 
no specific factor would increase their willingness to get the influenza vaccine from a 177 
pharmacist. Of these respondents, two-thirds (65.6%, n=122) reported not wanting or needing 178 
the influenza vaccine as the primary reason for not getting vaccinated by a pharmacist and 179 
94.6% (n=176) expressed a complete lack of interest in influenza vaccination by indicating 180 
“Nowhere (will not get it)” to the question that asked “Where do you plan to get the flu shot 181 
this year?” Almost two-thirds of these individuals had never had an influenza vaccination 182 
before (n=116, 62.4%). 183 
Slightly more than one-third of respondents (n=192, 35.5%) indicated that they visit their 184 
community pharmacy at least once a week, with younger individuals (<65) being less likely than 185 
their older counterparts to do so (OR 0.45, 95% CI: 0.30–0.67, p<0.01). Among respondents, 186 
42.1% (n=228) reported visiting their community pharmacy at least once a month and 20.5% 187 
(n= 111) reporting that they visit a few times a year. More flexible or extended hours (n=61, 188 
11.3%), shorter wait times (n=64, 11.8%), and more privacy at pharmacies (n=57, 10.5%) were 189 
reported as specific factors that would increase the willingness of individuals to get the flu shot 190 
from a pharmacist. Table 3 provides the factors respondents indicated would increase patron 191 
willingness to get the influenza vaccine from a pharmacist. 192 
Table 3: Factors that would increase pharmacy patron willingness to get the flu shot from a 193 
pharmacist 194 
Factor (More than one factor could be chosen) Frequency 
(n=541) 
Nothing, I will not get a flu shot  186 (34.4%) 
Increased advertising/promotion 74 (13.7%) 
More flexible or extended hours (evenings, walk ins) 64 (11.8%) 
Shorter wait times 61 (11.3%) 
A more private space to get the shot 57 (10.5%) 
Increased pharmacists’ experience 40 (7.4%) 
More flu clinics in the pharmacy 40 (7.4%) 
The option to make an appointment with the pharmacist 36 (6.7%) 
Increased pharmacists’ training 31 (5.7%) 


















We demonstrate in this cross-sectional survey study that, almost one year after the 197 
introduction of influenza vaccination service by pharmacists in community pharmacies, two 198 
barriers to immunization at a community pharmacy still exist: lack of awareness of pharmacist-199 
administered immunization and perceived lack of necessity (i.e. complacency) to be 200 
vaccinated,
26
 both in general and at pharmacies. Influenza vaccination is the most effective 201 
public health measure to prevent influenza
27,28
 morbidity and mortality,
29-31
 work absenteeism, 202 
and lost productivity and earnings the illness causes.
32,33
 In 2000, Ontario’s Ministry of Health 203 
and Long-Term Care launched the Universal Influenza Immunization Program to provide free 204 
influenza vaccinations in physician offices, public health clinics, and workplaces to all Ontarians 205 
aged 6 months and older.
34
 To increase immunization coverage, in 2012 the Ministry gave 206 
injection-certified pharmacists the authority to immunize Ontarians aged 5 years or older.
19
 207 
Pharmacists and community pharmacies were targeted, as both this healthcare profession and 208 
the sites where many practice are highly accessible. Indeed, 91% of Ontario residents live 209 
within 5 km of a pharmacy and 65% live within 800 meters.
35
 Moreover, community pharmacies 210 
typically have more convenient hours of operation than physician offices and public health 211 
clinics. Some 51% of Canadians visit a community pharmacy at least once a month.
36
 Most 212 
pharmacies are open during evenings and weekends, and appointments are often unnecessary 213 
for services pharmacists provide. 214 
During the second year that Ontario’s community pharmacists could offer influenza 215 
immunizations, some 750,000 doses were administered during that influenza season, with 216 
approximately 50% of community pharmacies offering this new service. Although studies have 217 
found that recipients of pharmacist-administered vaccinations are very satisfied with the 218 
service,
15-19
 our study demonstrated that increasing the public’s awareness about this service is 219 
required.   220 
Our survey revealed that about one-third of respondents were unaware of the service, even 221 
among individuals who visit the pharmacy. Awareness was lower among younger individuals, 222 
















were also less likely to receive the vaccine every year regardless of vaccination venue. Chain, 224 
franchise, and independent community pharmacies may be able to overcome lack of awareness 225 
by improving their promotional efforts. Our survey revealed that a similar proportion of 226 
respondents became aware of the availability of pharmacist immunization through radio and 227 
TV advertisements as from in-pharmacy contact and promotion. Increased advertisement was 228 
reported as the factor with the highest potential to increase willingness to receive a vaccination 229 
from a pharmacist. The next two most important factors were extending hours and shortening 230 
wait times, both of which underscore the importance of highlighting the convenience of 231 
community pharmacies when developing influenza immunization promotional materials.  232 
As the collective public health goal of influenza immunization is to have everyone immunized 233 
each season, the venue where they are immunized is less important that they get immunized.  234 
Knowing that some clients will value pharmacist-provided vaccination based on convenience 235 
and that previous research shows that recipients are highly satisfied with pharmacist-236 
administered immunizations,
15-19
 public health officials and other primary care providers (i.e. 237 
family physicians and nurse practitioners) should promote pharmacist-administered vaccination 238 
to increase public awareness and uptake of this service. Vice versa, with some survey 239 
respondents indicating that they prefer to get vaccinated in their physician’s office, in the 240 
workplace or with public health, it is important for pharmacists to support and encourage these 241 
immunization venues. 242 
The SAGE working group states that “vaccination complacency exists where perceived risks of 243 
vaccine-preventable diseases are low and vaccination is not deemed a necessary preventive 244 
action”.
37
 In our survey, more than one-third of respondents (n=225, 41.6%) indicated not 245 
wanting or needing the influenza vaccine as the reason for not receiving the vaccine from a 246 
pharmacist, a finding consistent with the published literature across all HCPs who provide the 247 
vaccination.
38
 About one-third of respondents indicated they would not receive the influenza 248 
vaccine anywhere, yet 61.6% of respondents indicated that if a healthcare provider 249 
recommended a vaccine they would get vaccinated. These findings highlight the need for 250 
















receive the vaccine. Research is limited regarding pharmacist’s training, role, strategies and 252 
successes in overcoming vaccine hesitancy. However, given the high level of public trust 253 
pharmacists enjoy,
39
 and the frequent opportunities they have to talk to the public and those at 254 
high risk of getting influenza, pharmacists could be quite successful in overcoming vaccine 255 
hesitancy.   256 
Understanding the perspectives of different age groups could help pharmacists better target 257 
their efforts. Although younger individuals visit pharmacies less often, they indicated they were 258 
more likely to receive the influenza vaccine from a pharmacist in the future than were 259 
individuals 65 years of age or older. In contrast, older individuals reported they valued 260 
convenience and being accustomed to receiving the influenza vaccination from their physician 261 
or nurse and identified few factors that would increase their willingness to get the influenza 262 
vaccine from a pharmacist. 263 
When asked why they did not get the influenza vaccine from a pharmacist, few respondents 264 
expressed concerns about inadequate privacy or pharmacists not having sufficient experience 265 
or training to immunize. However, pharmacists should be prepared to address privacy concerns 266 
and reassure clients that they are professionally competent to provide immunizations. 267 
The study has several limitations. Although pharmacy patrons were surveyed at six community 268 
pharmacies, individuals who completed the survey were customers in a single retail pharmacy 269 
chain. Surveys at other pharmacies or pharmacy chains could have yielded different findings. 270 
Moreover, the survey was conducted using a small convenience sample of six pharmacies in the 271 
Greater Toronto Area, Canada’s most diverse and populous city. Thus, our findings may not be 272 
generalizable to smaller, rural communities.  273 
CONCLUSION 274 
Lack of public awareness about the availability of influenza vaccine administration by 275 
pharmacists is common, especially among younger patrons. It is essential for pharmacists to 276 
promote this service to increase influenza vaccination rates and for other healthcare 277 
















important public health service. Pharmacists have an opportunity to address vaccine hesitancy 279 
issues, both in general and those that are pharmacy specific, and to promote influenza 280 
vaccination to pharmacy patrons who have not taken advantage of this recent professional 281 
service.  282 
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